- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1211EUR$1,250USD£1,038GBP
- Report
- January 2022
- 200 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- January 2022
- 60 Pages
Global
From €3828EUR$3,950USD£3,279GBP
- Drug Pipelines
- July 2020
- 61 Pages
Global
From €1938EUR$2,000USD£1,660GBP
- Report
- April 2023
- 80 Pages
Global
From €3500EUR$3,869USD£3,103GBP
- Drug Pipelines
- March 2021
Global
From €1938EUR$2,000USD£1,660GBP
- Report
- April 2022
- 48 Pages
Global
From €1938EUR$2,000USD£1,660GBP
- Report
- June 2022
- 245 Pages
Global
From €5591EUR$5,769USD£4,788GBP
The Dust Mite Allergy Drugs market is a subset of the Allergy Drugs market, which is composed of medications used to treat allergic reactions. These drugs are typically divided into two categories: antihistamines and corticosteroids. Antihistamines are used to reduce the symptoms of allergies, such as sneezing, itching, and runny nose. Corticosteroids are used to reduce inflammation and swelling associated with allergies.
Dust mite allergies are caused by an allergic reaction to the proteins found in dust mite droppings. Dust mite allergy drugs are designed to reduce the symptoms of dust mite allergies, such as sneezing, coughing, and itchy eyes. These drugs are typically administered orally or through inhalation.
Some companies in the Dust Mite Allergy Drugs market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more
